Loading...
Loading...
Analysts at Credit Suisse upgraded Cubist Pharmaceuticals
CBST from “neutral” to “outperform.” The target price for Cubist Pharmaceuticals has been raised from $56 to $69. Cubist's shares closed at $57.00 yesterday.
Analysts at Benchmark upgraded Open Text
OTEX from “hold” to “buy.” The target price for Open Text is set to $85. Open Text's shares closed at $67.46 yesterday.
Analysts at Piper Jaffray upgraded Questcor Pharmaceuticals
QCOR from “neutral” to “overweight.” The target price for Questcor Pharmaceuticals has been raised from $41 to $74. Questcor's shares closed at $51.91 yesterday.
Analysts at JP Morgan upgraded Compass Minerals International
CMP from “underweight” to “neutral” The target price for Compass Minerals International has been raised from $65 to $66. Compass Minerals International's shares closed at $73.06 yesterday.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in